Last Updated: April 13, 2026

Editorial Review Process 2026

Our content is prepared for clarity, source transparency, and UK relevance. We prioritise official UK sources, including MHRA, NHS, NICE, and reputable professional guidance where appropriate. Before publication, pages are checked for factual consistency, unsupported claims, and compliance-sensitive wording.

We aim to avoid exaggerated benefit claims, guaranteed outcomes, unsafe self-medication advice, and unverified social-media style recommendations. Where evidence is limited or still developing, content is framed cautiously and linked to authoritative context.

Pages are reviewed again after material regulatory or safety updates. High-impact health pages, especially those covering semaglutide, GLP-1 medicines, side effects, and eligibility, are prioritised for timely review.